Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

51.43
Delayed Data
As of 4:00pm ET
 -0.46 / -0.89%
Today’s Change
37.38
Today|||52-Week Range
52.60
+33.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line-329.0M798.0M419.0M283.0M
 
 
 
 
 
Depreciation340.0M319.0M774.0M648.0M
 
 
 
 
 
Total Other Cash Flow1.0B297.0M563.0M522.0M
 
 
 
 
 
Funds From Operations1.0B1.4B1.8B1.5B
 
 
 
 
 
Extraordinary Items0.000.00-1.2B0.00
 
 
Funds From/For Other Operating Expenses-206.0M244.0M31.0M102.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.2B1.2B574.0M1.4B
 
 
 
 
 
 
InvestingIncrease In Investments-182.0M-1.8B-15.0M-13.0M
 
 
 
 
 
Decrease In Investments--3.7B1.7B239.0M
 
 
 
 
Capital Expenditures-312.0M-319.0M-272.0M-255.0M
 
 
 
 
 
Fixed Asset Disposal0.000.005.5B-1.0M
 
 
 
Net Assets From Acquisitions -66.0M-7.0M-13.0B0.00
 
 
 
 
Other Investing - Sources6.0M8.0M3.0M24.0M
 
 
 
 
 
Net Cash Flow Investing-554.0M1.6B-6.2B-6.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-397.0M-1.1B-1.5B26.0M
 
 
 
 
 
Long Term Borrowings-38.0M15.1B0.000.00
 
 
 
Long Term Debt Reduction-1.0M-1.0M-2.5B-2.0M
 
 
 
 
 
Net Proceeds Stock Sale76.0M42.0M129.0M57.0M
 
 
 
 
 
Common Preferred Redeemed-2.0M0.00-95.0M-3.0M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-384.0M-386.0M-460.0M-462.0M
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing0.00170.0M13.0M0.00
 
 
 
Net Cash Flow - Financing-746.0M13.5B-4.4B-384.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash5.0M-104.0M65.0M8.0M
 
 
 
 
 
 
Net Change In Cash-83.0M16.2B-10.0B961.0M